The medical board that has been overseeing the Mir Raza Ali case was abruptly reconstituted overnight, with the original eight‑member panel replaced by a new five‑member panel. Dr Sumaiyya, who had been serving as convener of the original board, is the only member retained in the new configuration and will continue to chair the proceedings.
Mir Raza Ali, a 32‑year‑old from Karachi, was admitted to a private hospital in late July after suffering a severe cardiac event. He died a week later, sparking accusations of medical negligence and prompting a formal inquiry. The case has attracted widespread media attention and has become a touchstone for discussions about patient safety and accountability in Pakistan’s healthcare system.
The decision to overhaul the board was announced by the Ministry of Health without prior consultation with the board’s members or the patient’s family. Sources say the change was justified on the grounds of “improving efficiency and reducing conflicts of interest,” but no detailed explanation has been released. The new panel will consist of five experts, but the identities of the additional members have not yet been disclosed.
Ali’s family has rejected the overnight reshuffle, stating that the new board’s composition is “unfair and opaque.” They have vowed to file a petition in the High Court to challenge the legitimacy of the new panel and to seek a review of the board’s findings. The family’s legal team has already begun drafting the necessary documents.
The move has reignited a debate over transparency and fairness in medical oversight. Critics argue that sudden changes to a board that is already under scrutiny undermine public confidence and may open the door to political interference. Supporters of the change claim that a leaner panel will expedite the investigation and reduce bureaucratic delays.
The next step will be a court hearing scheduled for early September, where the family’s petition will be considered. Meanwhile, patient advocacy groups are calling for a review of the procedures that allow such overnight changes to occur, urging the government to adopt clearer guidelines for the composition and operation of medical inquiry boards.